1. Roles of PTEN with DNA Repair in Parkinson’s Disease
   Mako Ogino et al, 2016, IJMS CrossRef
2. Optimized Biotransformation of Icariin into Icariside II byβ-Glucosidase fromTrichoderma virideUsing Central Composite Design Method
   Tao Cheng et al, 2016, BioMed Research International CrossRef
3. Noncoding RNAs in Growth and Death of Cancer Cells.
   Anfei Liu et al, 2016 CrossRef
4. Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats
   Tao Cheng et al, 2015, Molecules CrossRef
5. The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II
   Meixia Chen et al, 2016, Nutrients CrossRef
6. Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model
   Jaganathan Kowshik et al, 2017, Sci Rep CrossRef
7. Metabolism profiles of icariin in rats using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and in vitro enzymatic study
   Tao Cheng et al, 2016, Journal of Chromatography B CrossRef
8. Icariin induces apoptosis in acute promyelocytic leukemia by targeting PIM1
   Hong Zhang et al, 2017, Pharmacological Reports CrossRef
9. Icarisid II inhibits the proliferation of human osteosarcoma cells by inducing apoptosis and cell cycle arrest
   Yuanyuan Tang et al, 2017, Tumour Biol. CrossRef
10. Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4.
    Zuopeng Wang et al, 2017, Oncol Lett CrossRef
11. Antigen-adjuvant effects of icariin in enhancing tumor-specific immunity in mastocytoma-bearing DBA/2J mice
    Xiaodi Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. Icariin attenuates titanium particle-induced inhibition of osteogenic differentiation and matrix mineralization via miR-21-5p
    Feng Lian et al, 2018, Cell Biol Int CrossRef
13. Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade
    Young Yun Jung et al, 2018, Front. Pharmacol. CrossRef
14. MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
    Ruonan Liu et al, 2018, Cancer Med CrossRef
15. Icariin reduces human colon carcinoma cell growth and metastasis by enhancing p53 activities.
    Meili Tian et al, 2018, Braz J Med Biol Res CrossRef
16. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5
    Lizhen Zhu et al, 2018, J Cell Physiol CrossRef
17. miR-21 and miR-19b delivered by hMSC-derived EVs regulate the apoptosis and differentiation of neurons in patients with spinal cord injury
    Guanghui Xu et al, 2018, J Cell Physiol CrossRef
18. Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells.
    Lei Fang et al, 2019, Biomed Pharmacother CrossRef
19. Redox-Sensitive, PEG-Shielded Carboxymethyl PEI Nanogels Silencing MicroRNA-21, Sensitizes Resistant Ovarian Cancer Cells to Cisplatin
    Sanaz Javanmardi et al, 2018, Asian Journal of Pharmaceutical Sciences CrossRef
20. Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses
    Satoru Matsuda et al, 2019, Diseases CrossRef
21. Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression
    Meng-dong Liu et al, 2016, Acta Pharmacol Sin CrossRef
22. Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
    Yan Dong et al, 2019, Front. Pharmacol. CrossRef
23. Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM
    Xia Cheng et al, 2019, Breast Cancer CrossRef
24. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
    Mohammad Mirza Aghazadeh Attari et al, 2019, DNA Repair CrossRef
25. A Review on the Effect of Plant Extract on Mesenchymal Stem Cell Proliferation and Differentiation
    Bhuvan Saud et al, 2019, Stem Cells International CrossRef
26. Effects of icariin on long noncoding RNA and mRNA expression profile in the aortas of apoE-deficient mice
    Yibing Zhang et al, 2019, Biosci. Rep. CrossRef
27. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1αsignalling
    Bo Xu et al, 2015, Clin Exp Pharmacol Physiol CrossRef
28. MicroRNAs: New players in intervertebral disc degeneration
    Cheng Wang et al, 2015, Clinica Chimica Acta CrossRef
29. Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy
    Alessandra Ferraresi et al, 2017, Mol. Carcinog. CrossRef
30. Genetic diversity, LCMS based chemical fingerprinting and antioxidant activity of Epimedium elatum Morr & Decne
    Sajad Ahmad Lone et al, 2017, Journal of Applied Research on Medicinal and Aromatic Plants CrossRef
31. Icariside II inhibits lipopolysaccharide-induced inflammation and amyloid production in rat astrocytes by regulating IKK/IκB/NF-κB/BACE1 signaling pathway
    Yong Zheng et al, 2019, Acta Pharmacol Sin CrossRef
32. The inhibitory function of icariin in cell model of benign prostatic hyperplasia by upregulation of miR‐7
    Ning Han et al, 2019, BioFactors CrossRef
33. Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma
    Priyanka Gokulnath et al, 2019, Cancers CrossRef
34. A single‐nucleotide polymorphism in lnc‐LAMC2‐1:1 interferes with its interaction with miR‐128 to alter the expression of deleted in colorectal cancer and its effect on the survival rate of subjects with ovarian cancer
    Qian Wang et al, 2020, J Cell Biochem CrossRef
35. Icariin inhibits proliferation, migration, and invasion of medulloblastoma DAOY cells by regulation of SPARC
    Yan Yang et al, 2020, Phytotherapy Research CrossRef
36. Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells
    Nabil A. Alhakamy et al, 2020, Pharmaceutics CrossRef
37. Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma
    Jiang-Tao Zhong et al, 2017, Oncotarget CrossRef
38. MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression
    Chang Li et al, 2016, Oncotarget CrossRef
39. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology.
    Shuwan Wang et al, 2020, J Ethnopharmacol CrossRef
40. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway
    Xuehan Bi et al, 2020, Cancer Gene Ther CrossRef
41. Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis
    Hossein Tabatabaeian et al, 2020, Cancers CrossRef
42. Prognostic value of microRNA-21 in epithelial ovarian carcinoma
    Kun Ji et al, 2020 CrossRef
43. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells
    Usama A. Fahmy et al, 2020, Pharmaceutics CrossRef
44. Flavonoid display ability to target microRNAs in cancer pathogenesis
    Shilpi Singh et al, 2021, Biochemical Pharmacology CrossRef
45. Icariin stimulates osteogenesis and suppresses adipogenesis of human bone mesenchymal stem cells via miR-23a-mediated activation of the Wnt/β-catenin signaling pathway
    Yingxing Xu et al, 2021, Phytomedicine CrossRef
46. Association of LncRNA‐GAS5 gene polymorphisms and PBMC LncRNA‐GAS5 level with risk of systemic lupus erythematosus in Chinese population
    Chun‐Hong Liu et al, 2021, J Cell Mol Med CrossRef
47. Natural products in the reprogramming of Cancer epigenetics
    Rasha Irshad et al, 2021, Toxicology and Applied Pharmacology CrossRef
48. Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK
    Jingfei Zheng et al, 2021, Journal of Pharmacological Sciences CrossRef
49. A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer’s Disease, Aging, Cancer, Inflammation, and Diabetes
    Raushanara Akter et al, 2021, IJMS CrossRef
50. Fabrication of Chinese Traditional Medicines incorporated collagen biomaterials for human bone marrow mesenchymal stem cells
    Ruijie Wang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
51. Bioactive Compounds from Herbal Medicine Targeting Multiple Myeloma
    Coralia Cotoraci et al, 2021, Applied Sciences CrossRef
52. Isolation, characterization and in vitro cytotoxicity studies of bioactive compounds from Alseodaphne semecarpifolia Nees
    Ganadhal Puttaramaiah Chethankumara et al, 2021, Heliyon CrossRef
53. Nanocarriers in the Enhancement of Therapeutic Efficacy of Natural Drugs
    Xiuling Li et al, 2021, BIO Integration CrossRef
54. Development and Evaluation of Icariin-Loaded PLGA-PEG Nanoparticles for Potentiation the Proapoptotic Activity in Pancreatic Cancer Cells
    Nabil A. Alhakamy, 2021, AAPS PharmSciTech CrossRef
55. TGF-β1 Induces Epithelial-Mesenchymal Transition of Chronic Sinusitis with Nasal Polyps through MicroRNA-21
    Xun Li et al, 2019, Int Arch Allergy Immunol CrossRef
56. Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health
    Victor Stefan Ionescu et al, 2021, Antioxidants CrossRef
57. HPLC-DAD Fingerprints Combined With Multivariate Analysis of Epimedii Folium From Major Producing Areas in Eastern Asia: Effect of Geographical Origin and Species
    Ben Li et al, 2021, Front. Pharmacol. CrossRef
58. Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review
    Yosif Almoshari, 2022, Pharmaceutics CrossRef
59. Pleiotropic Effects of Icariside II on the Cardiovascular System: Novel Applications of Ethnopharmacology in Targeting Vascular Remodeling
    Chunxu Shan et al, 2022 CrossRef
60. BPA Decreases PDCD4 in Bovine Granulosa Cells Independently of miR-21 Inhibition
    Reem Sabry et al, 2022, IJMS CrossRef
61. Icaritin inhibits CDK2 expression and activity to interfere with tumor progression
    Chao Zhang et al, 2022, iScience CrossRef
62. Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer
    Yanjin Fu et al, 2022, Front. Oncol. CrossRef
63. Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective
    Yufang Liu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
64. Natural Products as Anticancer Agents: Current Status and Future Perspectives
    Abid Naeem et al, 2022, Molecules CrossRef
65. Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering
    Zahra Seyedi et al, 2023, JFB CrossRef